Investigating Changes in Vital Signs in Neonates

Launched by UNIVERSITY OF OXFORD · Sep 4, 2023

Keywords

ClinConnect Summary

This clinical trial is studying how different medical procedures and medications affect the vital signs of newborn babies, such as their heart rate and breathing. Monitoring these vital signs is very important in neonatal care, but every baby can react differently to treatments. By understanding these reactions better, doctors hope to provide more personalized care, which could lead to safer treatment options for each individual infant. The researchers will record vital signs continuously during various procedures and when babies are resting, to see how these signs change and what factors might influence them, like age or infections.

To participate in this study, infants must be born to mothers who are at least 16 years old and admitted to the Newborn Care Unit at John Radcliffe Hospital. The mother must also provide written consent for the baby to be included. Unfortunately, babies with certain chromosomal or serious congenital abnormalities cannot take part in the study. If eligible, participants can expect to have their vital signs monitored closely, helping to gather important information that could benefit future neonatal care.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• Infants will be eligible to be included in the study if they are:
• • Born to, or expected to be born to, a mother aged 16 or over
• • Admitted to the Newborn Care Unit, John Radcliffe Hospital, or anticipated delivery of a baby who will require admittance to the Newborn Care Unit at birth
• • Mother given informed written consent
• Exclusion Criteria:
• Infants will be ineligible if the following exclusion criteria applies:
• • • Known chromosomal abnormality or life-threatening congenital abnormality